Trials / Completed
CompletedNCT00688454
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,392 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study explores efficacy and safety of the lipid-lowering therapy with CRESTOR in statin-naive patients and in patients with previously unsuccessful statin therapy. This study was designed to investigate the dynamic of the lipid parameters and therapy tolerability during 8-10 weeks treatment with CRESTOR
Conditions
Timeline
- Start date
- 2007-02-01
- Completion
- 2008-01-01
- First posted
- 2008-06-03
- Last updated
- 2009-04-09
Source: ClinicalTrials.gov record NCT00688454. Inclusion in this directory is not an endorsement.